156 related articles for article (PubMed ID: 27026511)
21. Selective intrahepatic duct cannulation by using a triple-lumen catheter for endoscopic bilateral stenting in hilar cholangiocarcinoma.
Kim JY; Kang DH; Choi CW; Kim HW; Park SB; Kim DU
Gastrointest Endosc; 2010 Jul; 72(1):192-8. PubMed ID: 20546732
[TBL] [Abstract][Full Text] [Related]
22. [Photodynamic therapy for unresectable cholangiocarcinoma: does it really increase the survival time?].
Choi EK; Kim MH
Korean J Gastroenterol; 2005 Jun; 45(6):446; author reply 447. PubMed ID: 15973081
[No Abstract] [Full Text] [Related]
23. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
24. Reply to Letter: "Preoperative Endoscopic Nasobiliary Drainage in Patients With Suspected Hilar Cholangiocarcinoma; Better Than Endoscopic or Percutaneous Biliary Drainage?".
Kawashima H; Itoh A; Ohno E; Itoh Y; Ebata T; Nagino M; Goto H; Hirooka Y
Ann Surg; 2015 Aug; 262(2):e55-6. PubMed ID: 25072434
[No Abstract] [Full Text] [Related]
25. [Clinical pathology of cholangiocarcinoma (intrahepatic bile duct cancer)].
Yamamoto M
Nihon Geka Hokan; 1995 Nov; 64(6):129-30. PubMed ID: 8913088
[No Abstract] [Full Text] [Related]
26. Reply to "Imaging of Perihilar Cholangiocarcinoma".
Engelbrecht MR
AJR Am J Roentgenol; 2015 Sep; 205(3):W386. PubMed ID: 26295678
[No Abstract] [Full Text] [Related]
27. The use of radial endosonography findings in the prediction of cholangiocarcinoma in cases with distal bile duct obstructions.
Alper E; Arabul M; Buyrac Z; Baydar B; Ustundag Y; Celik M; Ünsal B
Hepatogastroenterology; 2013 Jun; 60(124):678-83. PubMed ID: 24046829
[TBL] [Abstract][Full Text] [Related]
28. Education and imaging. Hepatobiliary and pancreatic: cholangiocarcinoma in a double bile duct.
Yamamoto T; Nakahira A; Kubo S; Uenishi T; Ichikawa T; Hai S; Tanaka S; Hirohashi K
J Gastroenterol Hepatol; 2006 Dec; 21(12):1859. PubMed ID: 17074028
[No Abstract] [Full Text] [Related]
29. Distal cholangiocarcinoma.
Dickson PV; Behrman SW
Surg Clin North Am; 2014 Apr; 94(2):325-42. PubMed ID: 24679424
[TBL] [Abstract][Full Text] [Related]
30. Editorial: shining a light on cholangiocarcinoma-a new dawn for photodynamic therapy? Authors' reply.
Gonzalez-Carmona MA; Bolch M; Strassburg CP; Weismüller TJ
Aliment Pharmacol Ther; 2019 Apr; 49(7):953-954. PubMed ID: 30868630
[No Abstract] [Full Text] [Related]
31. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
[TBL] [Abstract][Full Text] [Related]
32. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.
Nishimura M; Naka S; Hanazawa K; Tani T; Fukami M; Okada S; Fujiyama Y
Dig Dis Sci; 2005 Nov; 50(11):2153-8. PubMed ID: 16240231
[No Abstract] [Full Text] [Related]
33. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the pancreaticobiliary ductal systems by intraductal US.
Levy MJ; Vazquez-Sequeiros E; Wiersema MJ
Gastrointest Endosc; 2002 Mar; 55(3):397-408. PubMed ID: 11868016
[No Abstract] [Full Text] [Related]
35. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
36. [Cholangiocarcinoma].
Burgos San Juan L
Rev Med Chil; 2008 Feb; 136(2):240-8. PubMed ID: 18483680
[TBL] [Abstract][Full Text] [Related]
37. Author's reply: Treatment of recurrent intrahepatic cholangiocarcinoma (Br J Surg 2012; 99: 1711-1717).
Boudjema K
Br J Surg; 2013 Mar; 100(4):574. PubMed ID: 23378208
[No Abstract] [Full Text] [Related]
38. Comment on: Clinicopathological study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin.
Allendorf J
Surgery; 2017 Jul; 162(1):94-95. PubMed ID: 28318553
[No Abstract] [Full Text] [Related]
39. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation.
Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C
Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956
[TBL] [Abstract][Full Text] [Related]
40. Comments on "Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results".
Kim JH
Cardiovasc Intervent Radiol; 2010 Feb; 33(1):226. PubMed ID: 19533225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
